FierceBiotech 9. Apr. 2026 Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders
FierceBiotech 17. März 2026 Roche inks Nvidia deal to bolster AI factory, speed up drug and diagnostic development
FierceBiotech 10. März 2026 Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
FierceBiotech 9. März 2026 Roche's oral SERD flunks phase 3 trial in 1st-line breast cancer, raising questions of mechanism's limits
FierceBiotech 6. März 2026 Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug
FierceBiotech 4. März 2026 Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
FierceBiotech 2. März 2026 Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
FierceBiotech 29. Jan. 2026 Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
FierceBiotech 9. Jan. 2026 Roche returns to MediLink with promise of $570M near-term payments for another ADC
FierceBiotech 6. Jan. 2026 In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
FierceBiotech 10. Dez. 2025 Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial
FierceBiotech 4. Dez. 2025 Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
FierceBiotech 2. Dez. 2025 Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge